Comparison between Bio Medica Laboratories IPO and Neochem Bio IPO.
Bio Medica Laboratories IPO is a SME Bookbuilding IPO proposed to list at NSE SME while Neochem Bio IPO is a SME Bookbuilding proposed to list at NSE SME.
| Bio Medica Laboratories IPO | Neochem Bio IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | NSE SME | NSE SME |
| Lead Managers | Narnolia Financial Services Ltd. | Vivro Financial Services Pvt.Ltd. |
| Registrar | Skyline Financial Services Pvt.Ltd. | MUFG Intime India Pvt.Ltd. |
| Market Maker | ||
| DRHP | DRHP  | DRHP |
| RHP | ||
| Anchor Investor | ||
| IPO Allotment URL |
The total issue size of Bio Medica Laboratories IPO is up to ₹0.00 Cr whereas the issue size of the Neochem Bio IPO is up to ₹0.00 Cr. The final issue price of Bio Medica Laboratories IPO is and of Neochem Bio IPO is .
| Bio Medica Laboratories IPO | Neochem Bio IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ||
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | ||
| Fresh Issue Size | 32,05,200 shares | 47,50,000 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| OFS Issue Size | 3,76,800 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 35,82,000 shares | 47,50,000 shares |
| Issue Size Total (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
Bio Medica Laboratories IPO opens on , while Neochem Bio IPO opens on . The closing date of Bio Medica Laboratories IPO and Neochem Bio IPO is , and , respectively.
| Bio Medica Laboratories IPO | Neochem Bio IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | ||
| Issue Close | ||
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | ||
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Bio Medica Laboratories IPO P/E ratio is , as compared to Neochem Bio IPO P/E ratio of .
| Bio Medica Laboratories IPO | Neochem Bio IPO | |
|---|---|---|
| Financials | EBITDA | EBITDA |
| Promoter Shareholding (Pre-Issue) | 99.99 | 91.12 |
| Promoter Shareholding (Post-Issue) | ||
| P/E Ratio | ||
| Market Cap | ||
| ROE | 99.59% | 48.82% |
| ROCE | 48.20% | 41.67% |
| Debt/Equity | 1.02 | 1.80 |
| EPS | ||
| RoNW | 99.59% | 48.82% |
In the Bio Medica Laboratories IPO Retail Individual Investors (RII) are offered 0 shares while in Neochem Bio IPO retail investors are offered 0 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in Bio Medica Laboratories IPO and 0 shares in Neochem Bio IPO.
| Bio Medica Laboratories IPO | Neochem Bio IPO | |
|---|---|---|
| Anchor Investor Reserveration | 0 shares | 0 shares |
| Market Maker Reserveration | 1,89,600 shares | 0 shares |
| QIB | 0 shares | 0 shares |
| NII | 0 shares | 0 shares |
| RII | 0 shares | 0 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 0 shares | 0 shares |
Bio Medica Laboratories IPO subscribed in total, whereas Neochem Bio IPO subscribed .
| Bio Medica Laboratories IPO | Neochem Bio IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | ||
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | ||
| Employee (times) | ||
| Other (times) | ||
| Total (times) |
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
